Physician-driven artificial intelligence enabled planning for intraprostatic dose escalation in under ten minutes. This is an ASCO Meeting Abstract from the 2023 ASCO Genitourinary Cancers Symposium.
Men with low testosterone should go for intramuscular rather than transdermal replacement formulations, according to a new clinical practice guideline from the American College of Physicians (ACP). In ...
ARSYNL Rx Launches Exclusive HypoSpray® Transdermal Testosterone Option, Marking a New Era in Hormone Support Dover, United States – February 5, 2026 / ARSYNL Rx / ARSYNL Rx, a leader in ...
Please provide your email address to receive an email when new articles are posted on . Adjunctive transdermal testosterone was well tolerated but not more effective than placebo for symptoms of ...
May 28, 2004 -- A buccal testosterone delivery system is superior to the transdermal system, according to the results of a randomized trial published in the May issue of the Journal of Clinical ...
Background: Hypopituitarism in women can cause adrenal and ovarian dysfunction, resulting in severe androgen deficiency. Although testosterone replacement therapy has been shown to be beneficial in ...
Testosterone therapy, no matter how it is delivered, raises the 6-month risk of venous thromboembolism (VTE) regardless of whether the men who take it have low levels of the hormone, a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results